Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus-2009-2010

被引：0

作者：

Skrahina, Alena ^{[1
]}

Khaliaukin, Andrei ^{[2
]}

Falzon, Dennis ^{[3
]}

Rusovich, Valiantsin ^{[4
]}

Dara, Masoud ^{[5
]}

Shyrayeu, Aliaksandr ^{[2
]}

Zhylevich, Liudmila ^{[6
]}

Zignol, Matteo ^{[3
]}

Hurevich, Hennadz ^{[1
]}

机构：

[1] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS

[2] Gomel Reg TB Hosp, Gomel, BELARUS

[3] World Hlth Org, STOP TB Dept, Geneva, Switzerland

[4] World Hlth Org, Country Off, Minsk, BELARUS

[5] World Hlth Org, Reg Off Europe, Copenhagen, Denmark

[6] Minist Hlth, Gen Directorate Med Care, Minsk, BELARUS

来源：

EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷

关键词：

Tuberculosis; -; management; MDR-TB; Monitoring;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2570

引用

页数：1

共 50 条

[31] The Battle Continues: An Interpretative Phenomenological Analysis of the Experiences of Multidrug-Resistant Tuberculosis (MDR-TB) Patients
Brigaste M.B.T.
Teh L.A.
Psychological Studies, 2018, 63 (1) : 9 - 18
[32] Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
Bonnet, Maryline
Bastard, Mathieu
Du Cros, Philipp
Atadjan, Khamraev
Kimenye, Kamene
Khurkhumal, Shazina
Hayrapetyan, Armen
Telnov, Alex
Hewison, Cathy
Varaine, Francis
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[33] GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB)
Mokaddas, E. M.
Ahmad, S.
Eldeen, H. S.
JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (06)
[34] A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB)
Gupta, R
Espinal, M
Beggs, A
Laing, R
Preger, J
Castro, K
Cegielski, JP
De Luca, N
Laserson, K
Walton, W
Wells, C
Erokhin, V
Mishin, V
Vassilieva, I
Karataev, ON
Drobniewski, F
Brander, L
Katila, ML
Malakhov, I
Safonova, S
Sheyanenko, O
Starchenkova, N
Farmer, P
Hiatt, H
Kim, J
Mukherjee, J
Murray, M
Becerra, M
Nardell, E
Palmero, DJ
Bonilla, C
Solovic, I
Mahmud, AM
Rahman, A
Melnyk, VM
Portaels, F
Creach, P
Billo, N
Repina, E
Rakhishev, G
Pechiorina, I
Squire, SB
Coker, R
Arora, VK
Sloutsky, A
Timperi, R
Henkens, M
Lafontaine, D
Slavuckij, A
Vezhnina, N
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (05) : 410 - 414
[35] Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus
Skrahina, Alena
Yatskevich, Natalia
Hurevich, Henadz
Grankov, Viatcheslav
Klimuk, Dmitry
Solodovnikova, Varvara
Viatushka, Dmitry
Skrahin, Aliaksandr
Gurbanova, Elmira
Dara, Masoud
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[36] MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
Kendall, Emily A.
Azman, Andrew S.
Cobelens, Frank G.
Dowdy, David W.
PLOS ONE, 2017, 12 (03):
[37] Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India
Sachin R Atre
Megan B Murray
Journal of Public Health Policy, 2016, 37 : 277 - 299
[38] Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
Liu, Yongge
Matsumoto, Makoto
Ishida, Hidekaza
Ohguro, Kinue
Yoshitake, Masuhiro
Gupta, Rajesh
Geiter, Lawrence
Hafkin, Jeffrey
TUBERCULOSIS, 2018, 111 : 20 - 30
[39] Increase in Multidrug-resistant Tuberculosis (MDR-TB) in Alberta Among Foreign-born Persons: Implications for Tuberculosis Management
Richard Long
Deanne Langlois-Klassen
Canadian Journal of Public Health, 2013, 104 : e22 - e27
[40] Multidrug-resistant tuberculosis (MDR-TB) in a black African carceral area: Experience of Mali
Toloba, Y.
Ouattara, K.
Soumare, D.
Kanoute, T.
Berthe, G.
Baya, B.
Konate, B.
Keita, M.
Diarra, B.
Cisse, A.
Camara, F. S.
Diallo, S.
REVUE DE PNEUMOLOGIE CLINIQUE, 2018, 74 (01) : 22 - 27

← 1 2 3 4 5 →